Form 4: Domicilium Real Estate Fund III LP SEC Form 4 Filing

Domicilium Real Estate Fund III LP reported the conversion of pre-funded warrants into 600,000 shares of Eloxx Pharmaceuticals common stock.

Summary

• Domicilium Real Estate Fund III LP exercised pre-funded warrants to acquire 238,422 shares of Eloxx Pharmaceuticals common stock.
• BKJLAGG, LLC, an entity advised by Domicilium, exercised pre-funded warrants to acquire 361,578 shares of Eloxx Pharmaceuticals common stock.
• The total transaction involved the conversion of 600,000 pre-funded warrants into common stock on June 10, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting a change in the form of security held by existing investors rather than a new capital event or operational shift.

Positives

• Increased direct equity ownership by major institutional holders.
• Conversion of warrants simplifies the capital structure by reducing outstanding derivative securities.

Negatives

• None identified in this specific filing.

Risks

• Ownership concentration: The reporting persons are subject to a 19.99% beneficial ownership limitation regarding the exercise of remaining warrants.

Future Outlook

The filing does not provide forward-looking guidance regarding company operations, focusing solely on the change in beneficial ownership.

Industry Context

StockSavvy.ai notes that institutional warrant conversions in small-cap pharmaceutical companies often signal long-term confidence from existing investors or a strategic move to increase voting power ahead of potential corporate milestones.

Comparison to Industry Standards

• The conversion of pre-funded warrants is a standard mechanism in biotech financing to manage dilution and regulatory ownership caps.
• The 19.99% ownership cap mentioned is a standard provision in institutional investment agreements to avoid triggering change-of-control provisions or complex regulatory filings.

Related Party Transactions

• The filing discloses that Domicilium Capital Partners LLC acts as investment adviser to the Fund, BKJLAGG, MSEK Charleston, and Bold Stroke Investments, all of which are under the management of Daniel Simon.

Stakeholder Impact

• Existing shareholders may see a shift in the composition of the shareholder base, though total beneficial ownership remains largely consistent.

Next Steps

• Reporting persons to file subsequent Form 4s once CIK codes are received for additional entities.

Key Dates

Keywords

Eloxx Pharmaceuticals, ELOX, Form 4, Insider Ownership, Warrant Conversion, Domicilium Real Estate Fund